The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
POSTTRANSPLANT DIABETES MELLITUS IN LIVER TRANSPLANT RECIPIENTS: RISK FACTORS, TEMPORAL RELATIONSHIP WITH HEPATITIS C VIRUS ALLOGRAFT HEPATITIS, AND IMPACT ON MORTALITY1
Abstract
BACKGROUND: Recent studies suggest an association between diabetes mellitus and hepatitis C virus (HCV) infection. Our aim was to determine (1) the prevalence and determinants of new onset posttransplant diabetes mellitus (PTDM) in HCV (+) liver transplant (OLT) recipients, (2) the temporal relationship between recurrent allograft hepatitis and the onset of PTDM, and (3) the effects of antiviral therapy on glycemic control. METHODS: Between January of 1991 and December of 1998, of 185 OLTs performed in 176 adult patients, 47 HCV (+) cases and 111 HCV (-) controls were analyzed. We reviewed and analyzed the demographics, etiology of liver failure, pretransplant alcohol abuse, prevalence of diabetes mellitus, and clinical characteristics of both groups. In HCV (+) patients, the development of recurrent allograft hepatitis and its therapy were also studied in detail. RESULTS: The prevalence of pretransplant diabetes was similar in the two groups, whereas the prevalence of PTDM was significantly higher in HCV (+) than in HCV (-) patients (64% vs. 28%, P=0.0001). By multivariate analysis, HCV infection (hazard ratio 2.5, P=0.001) and methylprednisolone boluses (hazard ratio 1.09 per bolus, P=0.02) were found to be independent risk factors for the development of PTDM. Development of PTDM was found to be an independent risk factor for mortality (hazard ratio 3.67, P<0.0001). The cumulative mortality in HCV (+) PTDM (+) versus HCV (+) PTDM (-) patients was 56% vs. 14% (P=0.001). In HCV (+) patients with PTDM, we could identify two groups based on the temporal relationship between the allograft hepatitis and the onset of PTDM: 13 patients developed PTDM either before or in the absence of hepatitis (group A), and 12 concurrently with the diagnosis of hepatitis (group B). In gr. B, 11 of 12 patients received antiviral therapy. Normalization of liver function tests with improvement in viremia was achieved in 4 of 11 patients, who also demonstrated a marked improvement in their glycemic control. CONCLUSION: We found a high prevalence of PTDM in HCV (+) recipients. PTDM after OLT was associated with significantly increased mortality. HCV infection and methylprednisolone boluses were found to be independent risk factors for the development of PTDM. In approximately half of the HCV (+) patients with PTDM, the onset of PTDM was related to the recurrence of allograft hepatitis. Improvement in glycemic control was achieved in the patients who responded to antiviral therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infections in Patients with Diabetes Mellitus
Joshi, N., Caputo, G. M., Weitekamp, M. R., & Karchmer, A. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412507 · Cited by 1,043
Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
Gane, E. J., Portmann, B. C., Naoumov, N. V., Smith, H. M., Underhill, J. A., Donaldson, P. T., Maertens, G., & Williams, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341302 · Cited by 969
Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., & Thomas, D. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00009 · Cited by 676
Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G., Zimmerman, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290235 · Cited by 659
Allison, M. E. D., Wreghitt, T., Palmer, C. R., & Alexander, G. J. M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80631-2 · Cited by 454
Caronia, S., Taylor, K., Pagliaro, L., Carr, C., Palazzo, U., Petrik, J., O'Rahilly, S., Shore, S., Tom, B. D., & Alexander, G. J. M. (1999) · Hepatology · doi:10.1002/hep.510300416 · Cited by 396
Increased Risk of Type 2 Diabetes in Noncirrhotic Patients With Chronic Hepatitis C Virus Infection
Knobler, H., Schihmanter, R., Zifroni, A., Fenakel, G., & Schattner, A. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.355 · Cited by 292
Quantitation of hepatitis C virus RNA in liver transplant recipients
Chazouilleres, O., Kim, M., Combs, C., Ferrell, L., Bacchetti, P., Roberts, J., Ascher, N. L., Neuwald, P., Wilber, J., Urdea, M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90759-5 · Cited by 277
Zein, N. N., Abdulkarim, A. S., Wiesner, R. H., Egan, K. S., & Persing, D. H. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80065-3 · Cited by 257
Gretch, D. R., Bacchi, C. E., Corey, L., Rosa, C. D., Lesniewski, R. R., Kowdley, K., Gown, A., Frank, I., Perkins, J. D., & Carithers, R. L. (1995) · Hepatology · doi:10.1002/hep.1840220102 · Cited by 188
Cited by
Diabetes Mellitus after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D., & Matas, A. J. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00010.x · Cited by 1,285
NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1
Davidson, J., Wilkinson, A., Dantal, J., Dotta, F., Haller, H., Hernandez, D., Kasiske, B. L., Kiberd, B., Krentz, A., Legendre, C., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000069952.49242.3e · Cited by 676
Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatment
Hwang, J. L., & Weiss, R. E. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2486 · Cited by 380
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328
Post-transplant diabetes mellitus in patients with solid organ transplants
Jenssen, T., & Hartmann, A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0137-7 · Cited by 278
Metadata
- Authors
- Baid, S., Cosimi, A. B., Lin Farrell, M., Schoenfeld, D. A., Feng, S., Chung, R. T., Tolkoff-Rubin, N., & Pascual, M.
- Venue
- Transplantation
- Published
- 2001-09
- Volume
- 72
- Issue
- 6
- Pages
- 1066-1072
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2092983614
- Cited by
- 284
- References
- 20
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: POSTTRANSPLANT DIABETES MELLITUS IN LIVER TRANSPLANT RECIPIENTS: RISK FACTORS, TEMPORAL RELATIONSHIP WITH HEPATITIS C VIRUS ALLOGRAFT HEPATITIS, AND IMPACT ON MORTALITY1. https://app.cochat.ai/papers/10.1097/00007890-200109270-00015
- The paper
- Baid, S., Cosimi, A. B., Lin Farrell, M., Schoenfeld, D. A., Feng, S., Chung, R. T., Tolkoff-Rubin, N., & Pascual, M. (2001). POSTTRANSPLANT DIABETES MELLITUS IN LIVER TRANSPLANT RECIPIENTS: RISK FACTORS, TEMPORAL RELATIONSHIP WITH HEPATITIS C VIRUS ALLOGRAFT HEPATITIS, AND IMPACT ON MORTALITY1. Transplantation. https://doi.org/10.1097/00007890-200109270-00015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.